1
Tom Dønnem,
David Kerr,
Leonid L. Nikitenko,
Francesco Pezzella
:
A Change of Hallmark: An Update
1
Falah Jabar Rahim,
Lill-Tove Rasmussen Busund,
Biagio Ricciuti,
Masoud Tafavvoghi,
Thomas Karsten Kilvær,
David J. Pinato
et al.:
Fully Automatic Content-Aware Tiling Pipeline for Pathology Whole Slide Images
Intelligence-Based Medicine 01. November 2025
DOI /
ARKIV
1
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Ana Paola Lombardi,
Irene D’arsiè,
Erna-Elise Paulsen
et al.:
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Frontiers in Oncology 25. September 2025
DOI /
ARKIV
1
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Frontiers in Immunology 2024
DOI /
ARKIV
1
Mehrdad Rakaee,
Masoud Tafavvoghi,
Biagio Ricciuti,
Joao V Alessi,
Alessio Cortellini,
Fabrizio Citarella
et al.:
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
1
Per Niklas Benzler Waaler,
Hasse Melbye,
Henrik Schirmer,
Markus Kreutzer Johnsen,
Tom Dønnem,
Johan Fredrik Ravn
et al.:
Algorithm for predicting valvular heart disease from heart sounds in an unselected cohort
Frontiers in Cardiovascular Medicine 2023
DOI /
ARKIV
1
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
1
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
1
Bente Ervik,
Tom Dønnem,
May Lill Johansen
:
Dying at “home” - a qualitative study of end-of-life care in rural Northern Norway from the perspective of health care professionals
BMC Health Services Research 2023
DOI /
ARKIV
1
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Ilona Halva Urbarova,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
et al.:
Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer
1
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl Sholl,
Weiwei Shi,
Joao V. Alessi
et al.:
Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC
JAMA Oncology 17. November 2022
DOI /
ARKIV
1
Therese H. Nøst,
Marit Holden,
Tom Dønnem,
Hege Bøvelstad,
Charlotta Rylander,
Eiliv Lund
et al.:
Transcriptomic signals in blood prior to lung cancer focusing on time to diagnosis and metastasis
1
Sissel Gyrid Freim Wahl,
Yan Dai Hong,
Elisabeth Fritzke Emdal,
Thomas Berg,
Tarje Onsøien Halvorsen,
Anine Larsen Ottestad
et al.:
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study
1
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
1
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
1
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021
DOI /
ARKIV
1
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
1
Bente Ervik,
Sigve Andersen,
Helge Skirbekk,
Tom Dønnem
:
Evaluating a centralised cancer support centre in the remote region of Northern Norway
Rural and remote health 02. September 2020
DOI /
ARKIV
1
Elin Richardsen,
Sigve Andersen,
Christian Melbø-Jørgensen,
Mehrdad Rakaee,
Nora Ness,
Samer Al-Saad
et al.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
1
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
1
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
et al.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
1
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
1
Tom Dønnem,
Andrew Reynolds,
Elizabeth A. Kuczynski,
Kevin C. Gatter,
Peter B. Vermeulen,
Robert S. Kerbel
et al.:
Non-angiogenic tumours and their influence on cancer biology
1
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
1
Thea K.W. Grindstad,
Elin Richardsen,
Sigve Andersen,
Kaja Konstanse Skjefstad,
Mehrdad Rakaee,
Tom Dønnem
et al.:
Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
Masoud Tafavvoghi,
Erna-Elise Paulsen,
Falah Jabar Rahim,
Sigve Andersen,
Ana Paola Lombardi,
Elin Richardsen
et al.:
51P Deep learning-based detection of non-angiogenic growth patterns in early-stage lung cancer
ESMO Real World Data and Digital Oncology 01. November 2025
DOI /
ARKIV
Per Niklas Benzler Waaler,
Magdalena Solveig Robertsen,
Erna-Elise Paulsen,
Sigve Andersen,
Elin Richardsen,
Åslaug Helland
et al.:
21P Integration of genomic and clinical data for relapse prediction in early-stage non-small cell lung cancer
ESMO Real World Data and Digital Oncology 01. November 2025
DOI /
ARKIV
Masoud Tafavvoghi,
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
A. Cortellini,
P. Lombardi
et al.:
219P Benchmarking state-of-the-art deep learning models for tumor-infiltrating lymphocytes (TILs) quantification
ESMO Real World Data and Digital Oncology 01. November 2025
DOI /
ARKIV
Mehrdad Rakaee,
Per Niklas Benzler Waaler,
Falah Jabar Rahim,
Krinio Giannikou,
Elio Adib,
Sigve Andersen
et al.:
Abstract 5366: DRAGEN pipeline validation for somatic variant detection in diagnostics using TSO500 panel
Cancer Research 21. April 2025
DOI /
ARKIV
M.S. Robertsen,
Per Niklas Benzler Waaler,
Sigve Andersen,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Sissel Gyrid Freim Wahl
et al.:
1802P Tissue tumor mutational burden and risk of recurrence in early-stage non-small cell lung cancer
Annals of Oncology 01. September 2025
DOI /
ARKIV
Mehrdad Rakaee,
Masoud Tafavvoghi,
A. Cortellini,
Sigve Andersen,
Falah Jabar Rahim,
L. Brunetti
et al.:
P1.11.62 Deep Learning Histopathology Model for PD-L1 (TPS) and Immunotherapy Outcome Prediction in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology 01. October 2025
DOI /
ARKIV
Elio Adib,
falah jabar,
Masoud Tafavvoghi,
Amin Nassar,
Lill-Tove Rasmussen Busund,
Tom Dønnem
et al.:
Artificial Intelligence-powered analysis of the tumor immune microenvironment in primary and metastatic colorectal cancer
Annals of Oncology 01. September 2024
DOI /
ARKIV
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
Masoud Tafavvoghi,
Elin Helmine Richardsen,
Sissel Gyrid Freim Wahl
et al.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
Annals of Oncology 01. September 2024
DOI /
ARKIV
Bente Ervik,
Tom Dønnem,
May Lill Johansen
:
Home-death in Rural North Norway - Health Care Professionals Perspectives
Mehrdad Rakaee,
Masoud Tafavvoghi,
Elio Adib,
Biagio Ricciuti,
Joao Alessi,
Alessio Cortellini
et al.:
Artificial intelligence algorithm developed to predict immune checkpoint inhibitors efficacy in non–small-cell lung cancer
Journal of Clinical Oncology 01. June 2023
DOI /
ARKIV
Kjetil Tasken,
Hege Elisabeth Giercksky Russnes,
Eline Aas,
Line Bjørge,
Egil Støre Blix,
Terje C. Ahlquist
et al.:
A national precision cancer medicine implementation initiative for Norway
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V Alessi
et al.:
Computational pathology by Artificial Intelligence (AI) on quantifying the lymphocytic infiltration predicts the immunotherapy response in NSCLC
Åslaug Helland,
Hege Elisabeth Giercksky Russnes,
Gro Live Fagereng,
Khalid Ibrahim Al-Shibli,
Yvonne Andersson,
Thomas Berg
et al.:
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5)
Journal of Translational Medicine 2022
DOI /
ARKIV
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Joao V.Alessi,
Alessio Cortellini
et al.:
Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V.Alessi
et al.:
Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC
Journal of Clinical Oncology 01. June 2022
DOI /
ARKIV
Ilona H. Urbarova,
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
et al.:
Increased Levels of mRNAs and miRNAs Associated with Imminent and Advanced Lung Cancer
Journal of Thoracic Oncology 2022
DOI /
ARKIV
Åslaug Helland,
Hege Elisabeth Giercksky Russnes,
Gro Live Fagereng,
Khalid Ibrahim Al-Shibli,
Yvonne Andersson,
Thomas Berg
et al.:
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
Therese Haugdahl Nøst,
Ilona Halva Urbarova,
Anne Heidi Skogholt,
Robin Mjelle,
Erna Elise Paulsen,
Tom Dønnem
et al.:
Increased levels of mRNAs and miRNAs associated with imminent and advanced lung cancer
Sigve Andersen,
Tom Dønnem
:
Krafttak mot kreft
Tom Dønnem,
Sigve Andersen
:
Jakter på kroppens krigerceller
Tom Dønnem
:
Lungekreftforskning i et samfunnspersepktiv
Tom Dønnem
:
Er angiogenese en "hallmark of cancer"? - paradigmeskifte og betydning for behandling
BestPractice nordic 2019
ARKIV
Tom Dønnem,
Sigve Andersen
:
Jakter på kroppens krigerceller
Kaja Konstanse Skjefstad,
Thea K.W. Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
et al.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]